SCHEMBL12508498

SCHEMBL12508498

O=C(Nc1ccc2[nH]c(=O)[nH]c2c1)C(=O)N1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.71

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 5/20 0.67
▸ GRIN2B Q13224 5/20 0.67
▸ GRIN2D O15399 4/20 0.67
▸ GRIN3B O60391 4/20 0.67
▸ GRIN2A Q12879 4/20 0.67
▸ GRIN2C Q14957 4/20 0.67
▸ GRIN3A Q8TCU5 4/20 0.67
▸ MAPT P10636 4/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12508252 0.89 GRIN2D (0.68) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL12508958 0.88 GRIN2D (0.53) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL12508754 0.84 GRIN1 (0.68) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL12508661 0.83 GRIN2D (0.69) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4552037 0.80 GRIN1 (1.00) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL12508665 0.77 CA12 (0.43) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL12232754 0.74 GRIN2D (0.64) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL22425346 0.74 MAPT (0.76) MAPTALDH1A1KDM4E
SCHEMBL10008957 0.74 PKM (0.67) MAPTALDH1A1SMN1; SMN2
SCHEMBL12232311 0.73 KCNH2 (0.49) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110172415-A1 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP SHIONOGI & CO., LTD. (JP) 2011-07-14 — — US disclosed
US-7935706-B2 Nitrogen-containing heterocycle derivatives substituted with cyclic group SHIONOGI & CO., LTD. (JP) 2011-05-03 — — US disclosed
US-7935706-B2 Nitrogen-containing heterocycle derivatives substituted with cyclic group SHIONOGI & CO., LTD. (JP) 2011-05-03 — — US disclosed
US-20090062261-A1 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP SHIONOGI & CO., LTD. (JP) 2009-03-05 — — US disclosed
US-20090062261-A1 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP SHIONOGI & CO., LTD. (JP) 2009-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172415-A1 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP NR4A1, NR0B2, NR0B1 GRIN1 23/4885GRIN2B 49/4885GRIN2D 91/4885
US-20090062261-A1 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP NR4A1, NR0B2, NR0B1 GRIN1 23/4885GRIN2B 49/4885GRIN2D 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback